Ireland

--:--IST

Latest

Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide

Subscribe

Registers› Irish medicines ›Dasatinib

Medicines register · Ireland

Dasatinib — medicines in Ireland

33 authorised products containing Dasatinib, from the HPRA register.

Source: HPRA open dataset ("Authorised or Transfer Pending Products"), CC BY 4.0. Complete coverage — all 10,296 authorised products are in this register. Synced 07 Oct 2026, 03:23 UTC

Narrow the register Reset

Search within results

Matches brand name, active substance, licence holder and licence number.

Browse by first letter

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0–9

Medicine

Active substance

Licence holder

Status

Dasatinib Accord Healthcare 100 mg film-coated tablets EU/1/24/1839/017-020

Dasatinib

Accord Healthcare S.L.U.

—

Dasatinib Accord Healthcare 140 mg film-coated tablets EU/1/24/1839/021-024

Dasatinib

Accord Healthcare S.L.U.

—

Dasatinib Accord Healthcare 20 mg film-coated tablets EU/1/24/1839/001-004

Dasatinib

Accord Healthcare S.L.U.

—

Dasatinib Accord Healthcare 50 mg film-coated tablet EU/1/24/1839/005-008

Dasatinib

Accord Healthcare S.L.U.

—

Dasatinib Accord Healthcare 70 mg film-coated tablets EU/1/24/1839/009-012

Dasatinib

Accord Healthcare S.L.U.

—

Dasatinib Accord Healthcare 80 mg film-coated tablets EU/1/24/1839/013-016

Dasatinib

Accord Healthcare S.L.U.

—

Dasatinib Clonmel 100 mg film-coated tablets PA0126/310/004

Dasatinib

Clonmel Healthcare Ltd

Marketed

Dasatinib Clonmel 20 mg film-coated tablets PA0126/310/001

Dasatinib

Clonmel Healthcare Ltd

Marketed

Dasatinib Clonmel 50 mg film-coated tablets PA0126/310/002

Dasatinib

Clonmel Healthcare Ltd

Marketed

Dasatinib Clonmel 70 mg film-coated tablets PA0126/310/003

Dasatinib

Clonmel Healthcare Ltd

Marketed

Dasatinib Krka 100 mg film-coated tablets PA1347/093/005

Dasatinib

KRKA, d.d., Novo mesto

Not marketed

Dasatinib Krka 140 mg film-coated tablets PA1347/093/006

Dasatinib

KRKA, d.d., Novo mesto

Not marketed

Dasatinib Krka 20 mg film-coated tablets PA1347/093/001

Dasatinib

KRKA, d.d., Novo mesto

Not marketed

Dasatinib Krka 50 mg film-coated tablets PA1347/093/002

Dasatinib

KRKA, d.d., Novo mesto

Not marketed

Dasatinib Krka 70 mg film-coated tablets PA1347/093/003

Dasatinib

KRKA, d.d., Novo mesto

Not marketed

Dasatinib Krka 80 mg film-coated tablets PA1347/093/004

Dasatinib

KRKA, d.d., Novo mesto

Not marketed

Dasatinib Teva 100 mg Film-coated Tablets PA1986/066/004

Dasatinib

Marketed

Dasatinib Teva 20 mg Film-coated Tablets PA1986/066/001

Dasatinib

Marketed

Dasatinib Teva 50 mg Film-coated Tablets PA1986/066/002

Dasatinib

Marketed

Dasatinib Teva 70 mg Film-coated Tablets PA1986/066/003

Dasatinib

Marketed

Mubucho 111 mg film-coated tablets PA1701/003/006

Dasatinib

Not marketed

Mubucho 16 mg film-coated tablets PA1701/003/001

Dasatinib

Marketed

Mubucho 40 mg film-coated tablets PA1701/003/002

Dasatinib

Marketed

Mubucho 55 mg film-coated tablets PA1701/003/003

Dasatinib

Marketed

Mubucho 63 mg film-coated tablets PA1701/003/004

Dasatinib

Not marketed

Mubucho 79 mg film-coated tablets PA1701/003/005

Dasatinib

Marketed

Sprycel 10 mg/mL powder for oral suspension EU/1/06/363/016

Dasatinib

Bristol-Myers Squibb Pharma EEIG

—

Sprycel 100 mg film-coated tablets EU/1/06/363/010-11

Dasatinib

Bristol-Myers Squibb Pharma EEIG

—

Sprycel 140 mg film-coated tablets EU/1/06/363/014-015

Dasatinib

Bristol-Myers Squibb Pharma EEIG

—

Sprycel 20 mg film-coated tablets EU/1/06/363/1-4-7

Dasatinib

Bristol-Myers Squibb Pharma EEIG

—

Sprycel 50 mg film-coated tablet EU/1/06/363/2-5-8

Dasatinib

Bristol-Myers Squibb Pharma EEIG

—

Sprycel 70 mg film-coated tablets EU/1/06/363/3-6-9

Dasatinib

Bristol-Myers Squibb Pharma EEIG

—

Sprycel 80 mg film-coated tablets EU/1/06/363/012-013

Dasatinib

Bristol-Myers Squibb Pharma EEIG

—

Cite this view

Priya Life Science (2026). Irish Medicines Register, filtered. Derived from the HPRA open dataset. Retrieved 7 October 2026. https://priyalifescience.com/medicines/substance/dasatinib

Download this register

GET /api/export.php?register=medicines-ie&format=csv Try the JSON export →

Regulatory information only — not medical advice. For the authoritative record see the HPRA register directly.